| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $60K | +1102.4% | +20.2% |
| Gross Profit | $60K | +1102.4% | +20.2% |
| R&D Expense | -$4K | -149.1% | -102.4% |
| SG&A Expense | $1.5M | -21.4% | -65.5% |
| Operating Income | -$2.3M | +18.0% | +56.1% |
| Pre-tax Income | -$2.5M | -374.2% | +57.4% |
| Net Income | -$2.5M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $103K | +404.6% | +40.9% |
| Accounts Receivable | $50K | +456.9% | +62.3% |
| Current Assets | $1.8M | -6.1% | +55.1% |
| Total Assets | $16.4M | -3.8% | -48.8% |
| Current Liabilities | $12.3M | +17.9% | -5.7% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$5.3M | — | — |
| Capital Expenditures | $53K | — | — |
| Investing Cash Flow | -$584K | — | — |
| Financing Cash Flow | $5.9M | — | — |
| Free Cash Flow | -$5.4M | — | — |
| -374.2% |
| +57.4% |
| EPS (Basic) | -$0.06 | -400.0% | +62.5% |
| EPS (Diluted) | -$0.06 | -400.0% | +62.5% |
| $12.9M |
| +14.4% |
| -9.0% |
| Stockholders' Equity | $3.5M | -39.7% | -80.5% |